Harmony Biosciences Holdings I (HRMY) — Free Cash Flow Yield
Biotech & Pharma
| Metric | Value |
|---|---|
| FCF Yield | 15.7% |
| Biotech & Pharma Sector Avg FCF Yield | 16.3% |
| Annual Free Cash Flow | $355M |
| Market Cap | $2.3B |
| P/E Ratio | 12.6x |
Harmony Biosciences Holdings I's FCF yield of 15.7% is below the Biotech & Pharma sector average (16.3%).
Frequently Asked Questions
What is Harmony Biosciences Holdings I's (HRMY) free cash flow yield?
Harmony Biosciences Holdings I's (HRMY) free cash flow yield is 15.7%. That is below the Biotech & Pharma sector average (16.3%).
Is HRMY's free cash flow yield good?
At 15.7%, HRMY's free cash flow yield is considered excellent — yields above 10% are generally excellent, 7–10% good, 4–7% fair, and below 4% weak, though context varies by sector and growth stage.
How much free cash flow does Harmony Biosciences Holdings I generate?
Harmony Biosciences Holdings I generated $355M in free cash flow, against a market cap of $2.3B.
How is free cash flow yield calculated?
Free cash flow yield = (Free Cash Flow ÷ Market Capitalization) × 100%. Free cash flow equals operating cash flow minus capital expenditures.
Data from public filings. Not investment advice. Calculate your own FCF yield →